CDKN2A and neoplasm: Although the gold standard for HPV differentiation is p16 immunohistochemistry and high-risk HPV testing of the tumor (HPV DNA), exosome-based HPV diagnostic offers faster results, the possibility of early information, even before taking a biopsy, and could also be applied to patients from whom biopsy cannot be obtained.